Literature DB >> 12502624

Treatment of hypertension in adults with diabetes.

Carlos Arauz-Pacheco, Marian A Parrott, Philip Raskin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502624     DOI: 10.2337/diacare.26.2007.s80

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  77 in total

Review 1.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

Review 2.  Renal protection in hypertensive patients: selection of antihypertensive therapy.

Authors:  René R Wenzel
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

Authors:  G F M Strippoli; C Bonifati; M Craig; S D Navaneethan; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 4.  Hypertension and the pregnancy complicated by diabetes.

Authors:  Gustavo F Leguizamón; Natalia P Zeff; Alberto Fernández
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

5.  Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.

Authors:  Vivian A Fonseca; J Hans Devries; Robert R Henry; Morten Donsmark; Henrik F Thomsen; Jorge Plutzky
Journal:  J Diabetes Complications       Date:  2014-01-21       Impact factor: 2.852

Review 6.  Acute effects of physical exercise in type 2 diabetes: A review.

Authors:  Ricardo Yukio Asano; Marcelo Magalhães Sales; Rodrigo Alberto Vieira Browne; José Fernando Vila Nova Moraes; Hélio José Coelho Júnior; Milton Rocha Moraes; Herbert Gustavo Simões
Journal:  World J Diabetes       Date:  2014-10-15

Review 7.  Targeting hypertension in patients with cardiorenal metabolic syndrome.

Authors:  Edward Rojas; Manuel Velasco; Valmore Bermúdez; Zafar Israili; Peter Bolli
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 8.  Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

Authors:  Janet B McGill
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

Review 9.  Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.

Authors:  Katherine F Croom; Monique P Curran; Karen L Goa; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.

Authors:  Giovanni F M Strippoli; Maria Craig; Jonathan J Deeks; Francesco Paolo Schena; Jonathan C Craig
Journal:  BMJ       Date:  2004-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.